Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
Økonomi & Business
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Release date
Lydbog: 12. november 2020
Tags
Dansk
Danmark